2min chapter

The Top Line cover image

Misconduct and the future of neurodegenerative disease research

The Top Line

CHAPTER

Investigating Misconduct in Alzheimer's Research

This chapter explores the investigative efforts regarding alleged misconduct linked to Cassava Sciences and its Alzheimer's drug, Simufalam. It highlights the integrity concerns that arose from the data and the broader implications for patients in clinical trials, pointing to a significant crisis in neurodegenerative disease research.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode